Prospective Study
Copyright ©The Author(s) 2023.
World J Gastrointest Surg. Sep 27, 2023; 15(9): 2052-2062
Published online Sep 27, 2023. doi: 10.4240/wjgs.v15.i9.2052
Table 1 Patient characteristics
Characteristic
Number of patients
Percentage
Total patients100100%
Men5757%
Women4343%
Tumour location
Rectum5252%
Sigmoid colon2626%
Ascending colon1212%
Descending colon1010%
Tumour stage
Stage I2121%
Stage II2929%
Stage III3535%
Stage IV1515%
Metastasis
Lymph node metastasis5050%
Distant metastasis1515%
Table 2 Correlations between contrast-enhanced ultrasound parameters and angiogenesis markers
Parameters
Pearson correlation coefficient (r)
P value
PI and VEGF0.73< 0.001
PI and MVD0.75< 0.001
TTP and VEGF-0.68< 0.001
TTP and MVD-0.72< 0.001
AUC and VEGF0.71< 0.001
AUC and MVD0.74< 0.001
Table 3 Associations between contrast-enhanced ultrasound parameters, angiogenesis markers, and clinicopathological characteristics

Tumour stage
Lymph node metastasis
Distant metastasis
Age (yr)
Sex
PIP < 0.001P < 0.001P < 0.001NSNS
TTPP < 0.001P < 0.001P < 0.001NSNS
AUCP < 0.001P < 0.001P < 0.001NSNS
VEGF expressionP < 0.001P < 0.001P < 0.001NSNS
MVDP < 0.001P < 0.001P < 0.001NSNS
Table 4 Multivariate analysis of prognostic factors for overall survival and disease-free survival
Prognostic factor
Hazard ratio (OS)
95%CI (OS)
P value (OS)
Hazard ratio (DFS)
95%CI (DFS)
P value (DFS)
VEGF expression2.471.31-4.650.0052.311.24-4.320.008
MVD2.811.49-5.300.0012.671.42-5.030.002
PI2.551.36-4.780.0032.381.28-4.420.006
TTP2.341.24-4.410.0082.261.20-4.260.011
AUC2.621.38-4.960.0032.541.34-4. 810.004